2019
DOI: 10.1073/pnas.1900703116
|View full text |Cite
|
Sign up to set email alerts
|

TMEM16A controls EGF-induced calcium signaling implicated in pancreatic cancer prognosis

Abstract: SignificanceCancer of the pancreas is highly heterogeneous. Improvement of diagnosis and prognosis requires the discovery of new biomarkers and new methods of classification. In this study, we identify TMEM16A calcium-activated chloride channel as a potential key biomarker for pancreatic cancer. We demonstrate that, through the modulation of chloride homeostasis and the initiation of a calcium signaling pathway, TMEM16A is an important regulator of ligand-induced EGFR signaling in pancreatic cancer cells. Take… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
50
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 63 publications
(53 citation statements)
references
References 45 publications
2
50
1
Order By: Relevance
“…This is the case for KCa3.1 (Jiang et al, 2017), STIM1 (Wang et al, 2019), TRPM8 (Liu et al, 2018), TRPV6 (Song et al, 2018), TMEM16J (Jun et al, 2017), CLIC1 (Lu et al, 2015;Jia et al, 2016), and AQP1/AQP3 (Zou et al, 2019). The same correlation was obtained on gene expression using qPCR for TRPM8 (Du et al, 2018) or TCGA for TRPM2 (Lin et al, 2018) and TMEM16A (Crottes et al, 2019). Furthermore, the mutation status of TRPM2 was also analyzed using Kaplan-Meier in 10 patients out of 159, and the mutated TRPM2 gene revealed a negative correlation with patient survival, compared to patients expressing wildtype TRPM2 (Lin et al, 2018).…”
Section: Prognostic Markers Of Cancer Progression and Aggressivenesssupporting
confidence: 70%
See 3 more Smart Citations
“…This is the case for KCa3.1 (Jiang et al, 2017), STIM1 (Wang et al, 2019), TRPM8 (Liu et al, 2018), TRPV6 (Song et al, 2018), TMEM16J (Jun et al, 2017), CLIC1 (Lu et al, 2015;Jia et al, 2016), and AQP1/AQP3 (Zou et al, 2019). The same correlation was obtained on gene expression using qPCR for TRPM8 (Du et al, 2018) or TCGA for TRPM2 (Lin et al, 2018) and TMEM16A (Crottes et al, 2019). Furthermore, the mutation status of TRPM2 was also analyzed using Kaplan-Meier in 10 patients out of 159, and the mutated TRPM2 gene revealed a negative correlation with patient survival, compared to patients expressing wildtype TRPM2 (Lin et al, 2018).…”
Section: Prognostic Markers Of Cancer Progression and Aggressivenesssupporting
confidence: 70%
“…This indicates that TMEM16A is involved in EGF-induced PDAC migration and progression, probably through Ca 2+ signaling. In addition, this study investigated the possible role of TMEM16A to classify PDAC patients (Crottes et al, 2019). They found 10 genes involved in EGF-induced TMEM16A-dependent Ca 2+ signaling, which could distinguish neuro-endocrine tumors from other pancreatic cancers.…”
Section: Chloride Channels In Pdacmentioning
confidence: 99%
See 2 more Smart Citations
“…ANO1-mediated CaCC can be also induced by non-GPCR agonists. For example, the receptor tyrosine kinase (RTK) ligand EGF stimulated a transient calcium response and activated CaCC in the pancreatic cancer cell line AsPC-1, which was inhibited by ANO1 knockdown ( Crottes et al, 2019 ). Likewise, brain-derived neurotrophic factor (BDNF), acting through tropomyosin-related kinase (Trk) receptors ( Binder and Scharfman, 2004 ), induced robust Cl – currents, and these effects were blocked by pharmacological inhibition of ANO1 or by ANO1 knockout ( Hong et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%